Skip to content

A randomized controlled trial of CA-F17 in standard smoking cessation program for nicotine dependence

A randomized controlled trial of CA-F17 in standard smoking cessation program for nicotine dependence - A randomized controlled trial of CA-F17 in standard smoking cessation program for nicotine dependence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031589
Enrollment
580
Registered
2018-03-14
Start date
2017-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nicotine dependence

Interventions

One-time dispense of CA-F17 in conjunction with 3 months of Standard Treatment of Nicotine Dependence 3 months of Standard Treatment of Nicotine Dependence

Sponsors

CureApp, Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cases using a smartphone, diagnosed as nicotine dependent in tobacco dependence screening test who intend to quit smoking immediately

Exclusion criteria

Exclusion criteria: Cases judged difficult to participate in the trial, such as severe mental illness

Design outcomes

Primary

MeasureTime frame
9-24 week Continuous Abstinence Rate

Countries

Japan

Contacts

Public ContactTomoyasu Muto

CureApp, Inc. Clinical and Regulatory Affairs Department

clinreg_admin@cureapp.jp03-6231-0183

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026